519 related articles for article (PubMed ID: 16710296)
1. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.
Malakhova OA; Kim KI; Luo JK; Zou W; Kumar KG; Fuchs SY; Shuai K; Zhang DE
EMBO J; 2006 Jun; 25(11):2358-67. PubMed ID: 16710296
[TBL] [Abstract][Full Text] [Related]
2. UBP43, an ISG15-specific deconjugating enzyme: expression, purification, and enzymatic assays.
Kim KI; Zhang DE
Methods Enzymol; 2005; 398():491-9. PubMed ID: 16275353
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling.
Kim KI; Malakhova OA; Hoebe K; Yan M; Beutler B; Zhang DE
J Immunol; 2005 Jul; 175(2):847-54. PubMed ID: 16002682
[TBL] [Abstract][Full Text] [Related]
4. The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.
Tokarz S; Berset C; La Rue J; Friedman K; Nakayama K; Nakayama K; Zhang DE; Lanker S
J Biol Chem; 2004 Nov; 279(45):46424-30. PubMed ID: 15342634
[TBL] [Abstract][Full Text] [Related]
5. Protein ISGylation modulates the JAK-STAT signaling pathway.
Malakhova OA; Yan M; Malakhov MP; Yuan Y; Ritchie KJ; Kim KI; Peterson LF; Shuai K; Zhang DE
Genes Dev; 2003 Feb; 17(4):455-60. PubMed ID: 12600939
[TBL] [Abstract][Full Text] [Related]
6. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.
Kim KI; Yan M; Malakhova O; Luo JK; Shen MF; Zou W; de la Torre JC; Zhang DE
Mol Cell Biol; 2006 Jan; 26(2):472-9. PubMed ID: 16382139
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signalling protein SOCS1 and UBP43 regulate the expression of type I interferon-stimulated genes in human microvascular endothelial cells infected with Rickettsia conorii.
Colonne PM; Sahni A; Sahni SK
J Med Microbiol; 2013 Jul; 62(Pt 7):968-979. PubMed ID: 23558133
[TBL] [Abstract][Full Text] [Related]
8. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice.
Knobeloch KP; Utermöhlen O; Kisser A; Prinz M; Horak I
Mol Cell Biol; 2005 Dec; 25(24):11030-4. PubMed ID: 16314524
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages.
Zou W; Kim JH; Handidu A; Li X; Kim KI; Yan M; Li J; Zhang DE
Biochem Biophys Res Commun; 2007 Apr; 356(1):193-9. PubMed ID: 17349616
[TBL] [Abstract][Full Text] [Related]
10. Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling.
Yan M; Luo JK; Ritchie KJ; Sakai I; Takeuchi K; Ren R; Zhang DE
Blood; 2007 Jul; 110(1):305-12. PubMed ID: 17374743
[TBL] [Abstract][Full Text] [Related]
11. Ubp43 gene expression is required for normal Isg15 expression and fetal development.
Rempel LA; Austin KJ; Ritchie KJ; Yan M; Shen M; Zhang DE; Henkes LE; Hansen TR
Reprod Biol Endocrinol; 2007 Mar; 5():13. PubMed ID: 17381847
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3.
Malakhova O; Malakhov M; Hetherington C; Zhang DE
J Biol Chem; 2002 Apr; 277(17):14703-11. PubMed ID: 11854279
[TBL] [Abstract][Full Text] [Related]
13. The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression.
Kim JH; Luo JK; Zhang DE
J Immunol; 2008 Nov; 181(9):6467-72. PubMed ID: 18941237
[TBL] [Abstract][Full Text] [Related]
14. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.
Sarasin-Filipowicz M; Wang X; Yan M; Duong FH; Poli V; Hilton DJ; Zhang DE; Heim MH
Mol Cell Biol; 2009 Sep; 29(17):4841-51. PubMed ID: 19564419
[TBL] [Abstract][Full Text] [Related]
15. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of type I interferon signaling in normal and malignant cells.
Li Y; Srivastava KK; Platanias LC
Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
18. UBP43 (USP18) specifically removes ISG15 from conjugated proteins.
Malakhov MP; Malakhova OA; Kim KI; Ritchie KJ; Zhang DE
J Biol Chem; 2002 Mar; 277(12):9976-81. PubMed ID: 11788588
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of type I interferon signaling: facts and mechanisms.
Coccia EM; Uzé G; Pellegrini S
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):77-87. PubMed ID: 16914099
[TBL] [Abstract][Full Text] [Related]
20. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance.
Ketscher L; Hannß R; Morales DJ; Basters A; Guerra S; Goldmann T; Hausmann A; Prinz M; Naumann R; Pekosz A; Utermöhlen O; Lenschow DJ; Knobeloch KP
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1577-82. PubMed ID: 25605921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
